‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study – TCTMD
|
'Enhanced' Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study
TCTMD Enhanced multicellular therapy produced from autologous bone marrow led to significant improvements in clinical cardiac events in patients with heart failure and reduced ejection fraction due to ischemic dilated cardiomyopathy, a new study shows … Cell therapy reduces cardiac events in certain patients with HFrEF |
